Literature DB >> 4170149

Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.

M R Klemperer, V H Donaldson, F S Rosen.   

Abstract

When purified human C'1 esterase is injected intradermally in man, increased vascular permeability results. This effect is not blocked by soybean trypsin inhibitor and is not abolished by pretreatment with the antihistamine, pyribenzamine, or by compound 48/80. Thus, the effect is not due to the release of endogenous histamine. The decreased permeability response of individuals with a specific hereditary deficiency of C'2 is evidence for the complement-dependent nature of this reaction. The apparently normal response to intradermal C'1 esterase developed by individuals with an acquired specific deficiency of C'3 suggests that the vasoactive substance may be derived from one of the early reacting complement components. Characteristic attacks of angioedema have been provoked by the intradermal injection of human C'1 esterase in two individuals with hereditary angioneurotic edema. Patients with hereditary angioneurotic edema are unresponsive to intradermal injections of C'1 esterase immediately after attacks.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4170149      PMCID: PMC297206          DOI: 10.1172/JCI105756

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.

Authors:  A A MILES; D L WILHELM
Journal:  Br J Exp Pathol       Date:  1955-02

2.  Susceptibility of the guinea pig to pharmacological factors from its own serum.

Authors:  M E MACKAY; A A MILES; M SCHACHTER; D L WILHELM
Journal:  Nature       Date:  1953-10-17       Impact factor: 49.962

3.  Compound 48/80: a potent histamine liberator.

Authors:  W D M PATON
Journal:  Br J Pharmacol Chemother       Date:  1951-09

4.  Hereditary deficiency of the second component of complement (C'2) in man.

Authors:  M R Klemperer; H C Woodworth; F S Rosen; K F Austen
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

Review 5.  Hereditary angioneurotic edema: a clinical survey.

Authors:  V H Donaldson; F S Rosen
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

6.  Hereditary deficiency of the second component of complement (C'2) in man: further observations on a second kindred.

Authors:  M R Klemperer; K F Austen; F S Rosen
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

7.  A new type of inherited serum albumin anomaly.

Authors:  C B Laurell; J E Niléhn
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

8.  Anaphylatoxin in its relation to the complement system.

Authors:  J Jensen
Journal:  Science       Date:  1967-03-03       Impact factor: 47.728

9.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

10.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

2.  Complement in respiratory immunopathology.

Authors:  C Molina; J Brun; D Wahl
Journal:  Lung       Date:  1979       Impact factor: 2.584

3.  [Immunologic defense against infections].

Authors:  H G Schwick; K Heide
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1970

4.  Hereditary angioedema. A report of three families.

Authors:  F Kueppers; K H Schulz
Journal:  Humangenetik       Date:  1972

5.  Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.

Authors:  C A Alper; H R Colten; J S Gear; A R Rabson; F S Rosen
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Hereditary angio-oedema: treatment with C1 esterase inhibitor concentrate.

Authors:  R A Logan; M W Greaves
Journal:  J R Soc Med       Date:  1984-12       Impact factor: 5.344

7.  Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.

Authors:  J Kodama; K Uchida; S Yoshimura; Y Katayama; H Kushiro; C Yutani; S Funahashi; O Takamiya; Y Matsumoto; Y Ando
Journal:  Blut       Date:  1984-11

8.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

9.  Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

Authors:  V H Donaldson; O D Ratnoff; W Dias Da Silva; F S Rosen
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

10.  Hereditary angioneurotic oedema: an unusual cause of recurring abdominal pain.

Authors:  E J Feller; H M Spiro; L A Katz
Journal:  Gut       Date:  1970-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.